A detailed history of Kennedy Capital Management, Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 118,718 shares of BVS stock, worth $1.32 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
118,718
Previous 90,291 31.48%
Holding current value
$1.32 Million
Previous $519,000 173.22%
% of portfolio
0.03%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.73 - $11.95 $162,886 - $339,702
28,427 Added 31.48%
118,718 $1.42 Million
Q2 2024

Aug 14, 2024

SELL
$3.96 - $6.93 $118,178 - $206,811
-29,843 Reduced 24.84%
90,291 $519,000
Q1 2024

May 15, 2024

BUY
$4.33 - $5.75 $208,320 - $276,638
48,111 Added 66.8%
120,134 $624,000
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $15,799 - $29,193
5,467 Added 8.21%
72,023 $379,000
Q3 2023

Nov 14, 2023

BUY
$2.8 - $4.94 $186,356 - $328,786
66,556 New
66,556 $219,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $686M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.